8-K Announcements
6Material company update
May 4, 2026·SEC
Material company update
Apr 23, 2026·SEC
Material company update
Jan 29, 2026·SEC
Utah Medical Products, Inc.(UTMD)Earnings, Financials & Key Ratios
UTMD•NASDAQ
$69.33
19.9× P/E·Price updated Jul 7, 2026
AboutUtah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.Show more
- Revenue$39M-5.8%
- EBITDA$14M-12.3%
- Net Income$11M-18.7%
- EPS (Diluted)3.48-12.1%
- Gross Margin51.6%-12.6%
- EBITDA Margin37.26%-6.9%
- Operating Margin29.6%-10.9%
- Net Margin29.3%-13.6%
- ROE9.54%-15.5%
UTMD Price & Volume
Utah Medical Products, Inc. (UTMD) stock price & volume — 10-year historical chart
Loading chart...
Persistent Revenue Contraction Challenges Fortress Balance Sheet
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Contracting
Profitability:Strong
Financial:Fortress
Cash Flow:Robust
Primary Risk:Terminal revenue contraction risk
Key Thesis Takeaways
- Utah Medical Products maintains a fortress-like financial position with zero debt and $87.4 million in cash, yet the company faces a terminal growth risk characterized by persistent revenue contraction, which reached -10.2% in 2026Q1.
- While the firm exhibits exceptional operational efficiency with FCF margins of 34.2%, the lack of reinvestment suggests a strategic pivot toward capital preservation rather than market expansion.
- Investors should monitor whether the company's reliance on interest income to bolster net margins can offset the ongoing erosion of its core maternal and neonatal device market share.
Verdict Logic
while the company offers a 1.7% dividend yield and strong cash generation, the persistent revenue contraction and a high PEG ratio of 6.20 suggest limited upside potential for growth-oriented investors.
UTMD Growth Metrics
Utah Medical Products, Inc. (UTMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-0.42%
5 Years-1.8%
3 Years-9.68%
TTM-4.44%
Profit CAGR
10 Years-0.48%
5 Years0.89%
3 Years-11.84%
TTM-16.29%
EPS CAGR
10 Years1.03%
5 Years3.43%
3 Years-8.35%
TTM-10.58%
Return on Capital
10 Years16.46%
5 Years13.67%
3 Years11.31%
Last Year9.55%
UTMD Recent Earnings
Utah Medical Products, Inc. (UTMD) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
Apr 23, 2026Metric
Actual
Est
EPS
$0.82
—
Rev
$9M
—
Q1 2026
Jan 29, 2026Metric
Actual
Est
EPS
$0.80
—
Rev
$9M
—
Q4 2025
Oct 23, 2025Metric
Actual
Est
EPS
$0.82
—
Rev
$10M
—
Q3 2025
Jul 24, 2025Metric
Actual
Est
EPS
$0.94
—
Rev
$10M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 23, 2026 | $0.82 | $9M |
| Q1 2026 | Jan 29, 2026 | $0.80 | $9M |
| Q4 2025 | Oct 23, 2025 | $0.82 | $10M |
| Q3 2025 | Jul 24, 2025 | $0.94 | $10M |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Utah Medical Products, Inc. (UTMD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $69.33 | $220.75M | 19.92 | -5.83% | 29.3% | 9.54% | 1.77% | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $72.14 | $4.3B | 33.87 | 11.66% | 9.03% | 8.95% | — | |
| $105.70 | $2.41B | 41.94 | 13.53% | 24.35% | 16.19% | — | |
| $13.07 | $540.04M | -15.75 | -3.76% | -10% | -17.65% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — |
Compare UTMD vs Peers
Utah Medical Products, Inc. (UTMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
UTMD SEC Filings & Documents
Utah Medical Products, Inc. (UTMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when UTMD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
UTMD Frequently Asked Questions
Utah Medical Products, Inc. (UTMD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Utah Medical Products, Inc.'s revenue?
Utah Medical Products, Inc. (UTMD) reported $37.5M in revenue for fiscal year 2025. This represents a 3% decrease from $38.7M in 1996.
How fast is Utah Medical Products, Inc. growing?
Utah Medical Products, Inc. (UTMD) saw revenue decline by 5.8% over the past year.
Is UTMD profitable?
Yes, Utah Medical Products, Inc. (UTMD) is profitable, generating $10.8M in net income for fiscal year 2025 (29.3% net margin).
Dividend & Returns
Does UTMD pay dividends?
Yes, Utah Medical Products, Inc. (UTMD) pays a dividend with a yield of 1.77%. This makes it attractive for income-focused investors.
What is UTMD's return on equity?
Utah Medical Products, Inc. (UTMD) has a return on equity (ROE) of 9.5%. This is below average, suggesting room for improvement.
What is Utah Medical Products, Inc.'s free cash flow?
Utah Medical Products, Inc. (UTMD) generated $13.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.